Based on the provided data, the year-on-year variations observed for the forecasted antacid medicine sales in Chile are as follows:
- From 2024 to 2025: 0.39%
- From 2025 to 2026: 0.78%
- From 2026 to 2027: 0.39%
- From 2027 to 2028: 0.77%
The Compound Annual Growth Rate (CAGR) for the period 2024-2028 is approximately 0.58%.
In the coming years, factors such as the aging population, increasing prevalence of gastrointestinal disorders, and rising awareness of digestive health may drive steady growth in antacid medicine sales in Chile. Additionally, shifts in consumer preferences towards over-the-counter medication and advancements in pharmaceutical formulations are important trends to monitor.
